Ausgabe 3/2020
Inhalt (26 Artikel)
Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?
Samilia Obeng-Gyasi, Bridget Oppong, Electra D. Paskett, Maryam Lustberg
The influence of mastectomy and reconstruction on residual upper limb function in breast cancer survivors
Meghan E. Vidt, John Potochny, Daleela Dodge, Michael Green, Kathleen Sturgeon, Rena Kass, Kathryn H. Schmitz
Meta-analysis of prepectoral implant-based breast reconstruction: guide to patient selection and current outcomes
Olivia Abbate, Nikki Rosado, Nikhil Sobti, Brittany L. Vieira, Eric C. Liao
Hormone replacement therapy and mammographic density: a systematic literature review
Shadi Azam, Katja Kemp Jacobsen, Arja R. Aro, Elsebeth Lynge, Zorana Jovanovic Andersen
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
Maryam Althobiti, Abir A. Muftah, Mohammed A. Aleskandarany, Chitra Joseph, Michael S. Toss, Andrew Green, Emad Rakha
PIBF1 suppresses the ATR/CHK1 signaling pathway and promotes proliferation and motility of triple-negative breast cancer cells
Eun Ji Ro, Seung-Hee Ryu, Eun-Young Park, Je-Won Ryu, Sang Jun Byun, Seung-Ho Heo, Kang Hyun Kim, In-Jeoung Baek, Byung Ho Son, Sang-Wook Lee
ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients
Adwitiya Kar, Karen Koto, Darius Walker, Tammy Trudeau, Susan Edgerton, Ann Thor, Arthur Gutierrez-Hartmann
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer
Roberto A. Leon-Ferre, Edith A. Perez, David W. Hillman, Celyne Bueno, Alejandra T. Perez, Beiyun Chen, Robert B. Jenkins, Donald W. Northfelt, David B. Johnson, Robert L. Carolla, Robin T. Zon, Alvaro Moreno-Aspitia
The effect of 1-day multidisciplinary clinic on breast cancer treatment
Zohaib Akhtar, Vered Stearns, Paul Cartwright, Amanda L. Blackford, Vishnu Prasath, Catherine Klein, Danijela Jelovac, Fariba Asrari, Mehran Habibi
The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer
G. F. P. Aleixo, S. S. Shachar, A. M. Deal, K. A. Nyrop, H. B. Muss, Y. T. Chen, H. Yu, G. R. Williams
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns
Anna-Karin Tzikas, Szilard Nemes, Barbro K. Linderholm
Chronic adverse effects after an axillary lymphadenectomy in breast cancer patients after administering weaker and stronger postoperative analgesia: results of a prospective double-blind randomized study
Nikola Besic, Jaka Smrekar, Branka Strazisar
Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer
Mary D. Chamberlin, Jason D. Wells, Kevin Shee, Jennifer R. Bean, Jonathan D. Marotti, Wendy A. Wells, Heidi W. Trask, Fred W. Kolling, Ananta Bhatt, Peter A. Kaufman, Gary N. Schwartz, John M. Gemery, Nancy J. McNulty, Michael J. Tsapakos, Richard J. Barth, Bradley A. Arrick, Jiang Gui, Todd W. Miller
High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis
Michelle Specht, Nikhil Sobti, Nikki Rosado, Eleanor Tomczyk, Olivia Abbate, Dan Ellis, Eric C. Liao
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study
Binghe Xu, Wei Li, Qingyuan Zhang, Zhimin Shao, Qiao Li, Xiaojia Wang, Huiping Li, Tao Sun, Yongmei Yin, Hong Zheng, Jifeng Feng, Hong Zhang, Guiyuan Lei, Eleonora Restuccia
Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study
Anna Plym, Anna L. V. Johansson, Hannah Bower, Anna-Karin Wennstig, Irma Fredriksson, Johan Ahlgren, Mats Lambe
Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands
E. Heeg, M. B. Jensen, M. A. M. Mureau, B. Ejlertsen, R. A. E. M. Tollenaar, P. M. Christiansen, M. T. F. D. Vrancken Peeters
Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia
Jinfeng Zhang, Mingxi Lin, Yizi Jin, Linhan Gu, Ting Li, Baoying Yuan, Biyun Wang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Jian Zhang, Xichun Hu
A 15-year follow-up study on long-term adherence to health behaviour recommendations in women diagnosed with breast cancer
Daniel N. Tollosa, Elizabeth Holliday, Alexis Hure, Meredith Tavener, Erica L. James
Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population
Nupur Rani Howlader, Md. Mostafizur Rahman, Md. Amir Hossain, Razia Sultana, Syed Mozammel Hossain, Md. Abdul Mazid, Md. Mustafizur Rahman
Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins
María Jesús Ramírez-Expósito, José Manuel Martínez-Martos, Basilio Dueñas-Rodríguez, Joaquín Navarro-Cecilia, María Pilar Carrera-González
Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis
Thomas J. O’Keefe, Anne M. Wallace
Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients
Rodrigo Goncalves
Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Samantha Burugu, Meenakshi Anurag, Matthew J. Ellis, Torsten O. Nielsen